Development of the Scientific, Transparent and Applicable Rankings (STAR) tool for clinical practice guidelines

Yang, Nan; Liu, Hui; Zhao, Wei; Pan, Y; Lyu, Xiangzheng; Hao, Xiuyuan; Liu, Xiaoqing; Qi, Wenan; Chen, Tong; Wang, Xiaoqin; Zhang, Boheng; Zhang, Weishe; Li, Qiu; Xu, Dong; Gao, Xing‐Hua; Jin, Yinghui; Sun, Feng; Meng, Wenbo; Li, Guobao; Wu, Qi‐Jun; Chen, Ze; Xu, Weiting; Estill, Janne; Norris, Susan L.; Li, Du; Chen, Yaolong; Wei, Jun-min

doi:10.1097/cm9.0000000000002713

Cited by 9 publications

(5 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The “Registry” and “Protocol” of guidelines have potential in reducing duplication, improving collaboration, and increasing transparency [ 43 ]. These two domains were firstly added in the STAR tool, but not mentioned in the AGREE-II and RIGHT tools [ 24 – 26 ]. Since all the guidelines were developed before the STAR tool, it is not strange that all the included guidelines did not provide the register and protocol information.…”

Section: Discussionmentioning

confidence: 99%

“…Second, the STAR tool was a recently developed tool without wide validation compared to the AGREE-II and RIGHT tool. This tool has good reliability, validity, and efficiency [ 24 ], and has been validated in evaluations of hundreds of Chinese guidelines [ 28 , 29 ]. The weights of domains and items of STAR were subjectively determined, and the total score may be sensitive to the weighting [ 24 ].…”

Section: Discussionmentioning

confidence: 99%

“…This tool has good reliability, validity, and efficiency [ 24 ], and has been validated in evaluations of hundreds of Chinese guidelines [ 28 , 29 ]. The weights of domains and items of STAR were subjectively determined, and the total score may be sensitive to the weighting [ 24 ]. Nevertheless, this tool is still a timely tool for comprehensive evaluation of guidelines.…”

Section: Discussionmentioning

confidence: 99%

“…This tool includes bibliographical information, characteristics, and key recommendations. The same three reviewers independently evaluated the quality of included guidelines by using the Scientific, Transparent and Applicable Rankings (STAR) tool (Supplementary Table S 2 ) [ 24 ]. This tool not only covers the domains in the existing Appraisal of Guidelines for Research and Evaluation II (AGREE-II) [ 25 ] and Reporting Items for Practice Guidelines in Healthcare (RIGHT) [ 26 ] tool, but also includes extra elements of applicability, development transparency, and prospective registries, to allow a comprehensive evaluation [ 27 – 30 ].…”

Section: Methodsmentioning

confidence: 99%

See 3 more Smart Citations

Just give the contrast? Appraisal of guidelines on intravenous iodinated contrast media use in patients with kidney disease

Zhong,

Chen,

Xing

et al. 2024

Insights Imaging

View full text Add to dashboard Cite

Objective To appraise the quality of guidelines on intravenous iodinated contrast media (ICM) use in patients with kidney disease, and to compare the recommendations among them. Methods We searched four literature databases, eight guideline libraries, and ten homepages of radiological societies to identify English and Chinese guidelines on intravenous ICM use in patients with kidney disease published between January 2018 and June 2023. The quality of the guidelines was assessed with the Scientific, Transparent, and Applicable Rankings (STAR) tool. Results Ten guidelines were included, with a median STAR score of 46.0 (range 28.5–61.5). The guidelines performed well in “Recommendations” domain (31/40, 78%), while poor in “Registry” (0/20, 0%) and “Protocol” domains (0/20, 0%). Nine guidelines recommended estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2 as the cutoff for referring patients to discuss the risk-benefit balance of ICM administration. Three guidelines further suggested that patients with an eGFR < 45 mL/min/1.73 m2 and high-risk factors also need referring. Variable recommendations were seen in the acceptable time interval between renal function test and ICM administration, and that between scan and repeated scan. Nine guidelines recommended to use iso-osmolar or low-osmolar ICM, while no consensus has been reached for the dosing of ICM. Nine guidelines supported hydration after ICM use, but their protocols varied. Drugs or blood purification therapy were not recommended as preventative means. Conclusion Guidelines on intravenous ICM use in patients with kidney disease have heterogeneous quality. The scientific societies may consider joint statements on controversial recommendations for variable timing and protocols. Critical relevance statement The heterogeneous quality of guidelines, and their controversial recommendations, leave gaps in workflow timing, dosing, and post-administration hydration protocols of contrast-enhanced CT scans for patients with kidney diseases, calling for more evidence to establish a safer and more practicable workflow. Key points • Guidelines concerning iodinated contrast media use in kidney disease patients vary. • Controversy remains in workflow timing, contrast dosing, and post-administration hydration protocols. • Investigations are encouraged to establish a safer iodinated contrast media use workflow. Graphical Abstract

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Just give the contrast? Appraisal of guidelines on intravenous iodinated contrast media use in patients with kidney disease

Zhong,

Chen,

Xing

et al. 2024

Insights Imaging

View full text Add to dashboard Cite

show abstract

“…The STAR (Scientific, Transparent and Applicable Rankings) tool includes 39 items in 11 domains with weights reflecting their importance. 7 The STAR working group evaluates the quality of guidelines in various specialties, including cardiology, on a regular basis. Guideline users can retrieve the results of guideline evaluations free of charge from the STAR library and select the highest-quality guidelines for dissemination and use.…”

Section: Enhancing the Science And Transparency Of Cardiovascular Gui...mentioning

confidence: 99%

Recommendations for Improving the Quality of Chinese Cardiovascular Guidelines and Evidence

Yang,

Liu,

Estill

et al. 2024

JACC: Asia

Self Cite

View full text Add to dashboard Cite

A global review of acupuncture and moxibustion recommendations in guidelines/expert consensus for chemotherapy- and/or radiotherapy-induced nausea and/or vomiting

MING,

GANG,

SHI

et al. 2024

World Journal of Acupuncture - Moxibustion

View full text Add to dashboard Cite

Development of the Scientific, Transparent and Applicable Rankings (STAR) tool for clinical practice guidelines

Cited by 9 publications

References 29 publications

Just give the contrast? Appraisal of guidelines on intravenous iodinated contrast media use in patients with kidney disease

Just give the contrast? Appraisal of guidelines on intravenous iodinated contrast media use in patients with kidney disease

Recommendations for Improving the Quality of Chinese Cardiovascular Guidelines and Evidence

A global review of acupuncture and moxibustion recommendations in guidelines/expert consensus for chemotherapy- and/or radiotherapy-induced nausea and/or vomiting

Contact Info

Product

Resources

About